Progress of Researches on CTLA-4 Ig and Anti-Cd154mab in Organ Transplantation

XIA Ting,FANG Jian-pei
DOI: https://doi.org/10.3760/cma.j.issn.1673-4394.2012.04.001
2012-01-01
International Journal of Immunology
Abstract:CTLA-4 Ig and anti-CD154mAb (anti-CD154 monoclonal antibody) are the two novel biological immune inhibitors in the organ transplantation.They inhibit T lymphocyte activation by blocking co-stimulatory signal pathways,and playing an immune tolerance role in organ transplantation.Therefore,they would have a good application prospect in transplant tolerance.CTLA-4 Ig and anti-CD154mAb have been proved to be highly effective in immune tolerance by single or combined application,which can prolong transplant survival in various animal transplantation models.The clinical application is still in the initial stage,while their clinical side effects,safety and long-term efficacy need further observation.This review summarizes the two inbibitors' immunological characters,the mechanisms of their functions and their application in organ transplantation.
What problem does this paper attempt to address?